Ibrexafungerp VS Plasebo Untuk Terapi Kandidiasis Vulvovaginal – Telaah Jurnal Alomedika

Oleh :
dr.Eduward Thendiono, SpPD,FINASIM

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Schwebke JR, Sobel R, Gersten JK, et al. Clin Infect Dis. 2022 Jun 10;74(11):1979-1985. doi: 10.1093/cid/ciab750. PMID: 34467969

Abstrak

Referensi